San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.
Quidel Corporation Receives FDA Clearance For Its Lyra Molecular PCR Assay For The Detection Of Human Parainfluenza Viruses (HPIV), Types 1, 2 And 3
SAN DIEGO, CA–(Marketwired – October 15, 2014) – Highlighted Links Quidel DHI
IRVINE, CA–(Marketwired – October 16, 2014) – Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, announced financial results today for the first fiscal quarter ended August 31, 2014.Fiscal 2015 first quarter net sales for…
Two New Clinical Studies Show Masimo Corporation Noninvasive Hemoglobin (SpHb) Demonstrated Similar Precision As Hemoglobin From Point Of Care Devices
IRVINE, CA–(Marketwired – October 16, 2014) – Masimo (NASDAQ: MASI) announced two new studies today that showed that noninvasive hemoglobin (SpHb®) demonstrated similar accuracy as hemoglobin measured by invasive hemoglobin analyzers when both SpHb and the invasive…
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day on Tuesday, November 18, 2014 from 10:00 a.m. to 11:30 a.m. Eastern time (7:00 a.m. to 8:30 a.m. Pacific time) in New York City. The presentations will cover the following topics: Ligands business model and expanding portfolio of partnered and un-partnered assets Help employers find you…
Batu Biologics Awarded Exclusive License From University of California, San Diego (UCSD) for Drug That Stimulates Immune System To Kill Cancer
SAN DIEGO–(BUSINESS WIRE)–Batu Biologics, an immunotherapy company developing an anti-angiogenic cancer vaccine, announced today the signing of a license agreement with the Regents of the University of California, granting exclusive rights to novel peptide drugs developed at UC San Diego that have been proven to stimulate cancer-killing immune responses. Batu Biologics plans to utilize the licensed…
PORTLAND, Ore., Oct. 15, 2014 /PRNewswire/ –Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in
Bioinformatics giant Illumina (NASDAQ: ILMN) is getting into the accelerator game, along with other players in the life sciences and other fields. On Wednesday it announced the first three startups…
[[Click headline to continue reading.]]
Illumina Inc. announced the selection of three startup companies for the inaugural Illumina Accelerator funding cycle. The companies are Encoded Genomics Inc., EpiBiome Inc., and Xcell Biosciences Inc.
Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Human Parainfluenza Viruses (HPIV), Types 1, 2 and 3
SAN DIEGO, CA–(Marketwired – Oct 15, 2014) – Quidel Corporation ( NASDAQ : QDEL ), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its Lyra Parainfluenza Assay, a real-time PCR test for the qualitative detection and identification of human parainfluenza virus (HPIV) infections for virus types 1, 2, or 3 viral RNA extracted from nasal swab and nasopharyngeal swab specimens.
San Diego’s Flourishing Industrial Biotech Sector Provides the Backdrop for BIO’s 2014 Pacific Rim Summit on Industrial Biotech & Bioenergy
WASHINGTON–(BUSINESS WIRE)–San Diego-based industrial biotech companies continue to deliver next generation products and innovative technology solutions, many of which will be highlighted during the 2014 BIO Pacific Rim Summit.